Annexon, Inc. (NASDAQ:ANNX) Given Consensus Rating of "Hold" by Analysts

Key Points

• Analysts have assigned Annexon, Inc. a consensus rating of "Hold", with one sell rating, one hold rating, and three buy ratings, alongside an average 12-month price target of $12.50.
• Institutional investments have increased, with large investors acquiring new stakes during the second quarter, including Matauro LLC and Vanguard Personalized Indexing Management LLC.
• Annexon's stock saw a 2.6% rise, closing at $3.19, with the company reporting a slightly better-than-expected EPS of ($0.34) for the last quarter.

Shares of Annexon, Inc. (NASDAQ:ANNX - Get Free Report) have been assigned a consensus rating of "Hold" from the five analysts that are currently covering the company, MarketBeat reports. One analyst has rated the stock with a sell rating, one has given a hold rating and three have given a buy rating to the company. The average 12 month price target among brokers that have issued ratings on the stock in the last year is $12.50.

Several brokerages have commented on ANNX. Weiss Ratings restated a "sell (d-)" rating on shares of Annexon in a research note on Saturday, September 27th. HC Wainwright reiterated a "buy" rating and issued a $14.00 target price on shares of Annexon in a research note on Friday, August 15th. Finally, Zacks Research upgraded Annexon from a "strong sell" rating to a "hold" rating in a research note on Monday, August 18th.

Institutional Investors Weigh In On Annexon

Large investors have recently modified their holdings of the stock. Matauro LLC acquired a new stake in Annexon during the 2nd quarter valued at approximately $27,000. Vanguard Personalized Indexing Management LLC acquired a new stake in Annexon during the 2nd quarter valued at approximately $29,000. 49 Wealth Management LLC acquired a new stake in Annexon during the 2nd quarter valued at approximately $29,000. Engineers Gate Manager LP acquired a new stake in Annexon during the 2nd quarter valued at approximately $32,000. Finally, CWM LLC grew its stake in Annexon by 212.9% during the 2nd quarter. CWM LLC now owns 17,734 shares of the company's stock valued at $43,000 after purchasing an additional 12,066 shares in the last quarter.

Annexon Trading Up 2.6%

NASDAQ:ANNX traded up $0.08 on Friday, hitting $3.19. 1,518,152 shares of the stock were exchanged, compared to its average volume of 2,488,074. The stock has a market cap of $350.55 million, a PE ratio of -2.47 and a beta of 1.36. The stock has a fifty day moving average of $2.48 and a 200-day moving average of $2.26. Annexon has a fifty-two week low of $1.28 and a fifty-two week high of $7.85.

Annexon (NASDAQ:ANNX - Get Free Report) last announced its quarterly earnings results on Thursday, August 14th. The company reported ($0.34) EPS for the quarter, topping the consensus estimate of ($0.36) by $0.02. As a group, analysts predict that Annexon will post -0.96 earnings per share for the current year.

About Annexon

Annexon, Inc, a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. Its lead candidate is ANX005, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with guillain-barré syndrome; completed Phase II clinical trial for treating Huntington's disease; and in Phase II clinical trial for the treatment of amyotrophic lateral sclerosis.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.